Fibroblasts could serve as new key to enhancing personalized treatment for lung cancer patients

BOSTON – Three subtypes of cancer-associated fibroblasts (CAF) could guide the design of personalized treatment for lung cancer patients, according to

Related Keywords

Guangzhou ,Guangdong ,China ,Boston ,Massachusetts ,United States ,America ,Matthewj Niederst ,Leciav Sequist ,Huidong Chen ,Aaronn Hata ,Jeffreya Engelman ,Cyrilh Benes ,Zofia Piotrowska ,Medicine At Harvard Medical School ,Guangzhou Health Care Collaborative Innovation Major ,Cancer Center ,Harvard Medical School ,Research Institute ,Wellcome ,National Human Genome Research Institute ,Lung Cancer Research Foundation ,Cancer Cell ,Massachusetts General Hospital ,Mass General Cancer Center ,Harvard Medical ,Wellcome Trust ,Massachusetts General ,General Hospital ,Mass General Research Institute ,Mass General ,World Report ,Best Hospitals ,